Your browser doesn't support javascript.
loading
Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development.
Zaratin, P; Comi, G; Coetzee, T; Ramsey, K; Smith, K; Thompson, A; Panzara, M.
Affiliation
  • Zaratin P; Italian Multiple Sclerosis Foundation, Genoa, Italy. Electronic address: paola.zaratin@aism.it.
  • Comi G; Department of Neurology and Institute of Experimental Neurology (INSPE), Vita-Salute San Raffaele University, Ospedale San Raffaele, Milan, Italy.
  • Coetzee T; National Multiple Sclerosis Society, New York, USA.
  • Ramsey K; National Multiple Sclerosis Society, New York, USA.
  • Smith K; National Multiple Sclerosis Society, New York, USA.
  • Thompson A; Department of Brain Repair and Rehabilitation, Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Panzara M; WAVE Life Sciences, 733 Concord Avenue, Cambridge, MA 02138, USA.
Trends Pharmacol Sci ; 37(10): 808-810, 2016 10.
Article in En | MEDLINE | ID: mdl-27554755
ABSTRACT
The Progressive MS Alliance Industry Forum describes a new approach to address barriers to developing treatments for progressive multiple sclerosis (MS). This innovative model promises to facilitate robust collaboration between industry, academia, and patient organizations and accelerate research towards the overarching goal of developing safe and effective treatments for progressive MS.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Multiple Sclerosis, Chronic Progressive / Drug Discovery Limits: Humans Language: En Journal: Trends Pharmacol Sci Year: 2016 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Multiple Sclerosis, Chronic Progressive / Drug Discovery Limits: Humans Language: En Journal: Trends Pharmacol Sci Year: 2016 Document type: Article